Alterations in T Cell Subpopulations Linked to Brain Structure in Tardive Dyskinesia
By Elana Gotkine HealthDay Reporter
THURSDAY, July 25, 2024 -- Alterations in the proportion of T cell subpopulations are associated with brain structural abnormalities in patents with schizophrenia with tardive dyskinesia (TD), according to a study published in the July issue of Schizophrenia Research.
Na Li, from the Peking University HuiLongGuan Clinical Medical School in Beijing, and colleagues examined the correlations between distributions of T cell phenotypes and brain structure abnormalities in 50 schizophrenia patients with TD (TD) and 58 without TD (NTD), relative to 41 healthy controls (HC). Naive (CD45RA+), memory (CD45RO+), and apoptotic (CD95+) CD4+ and CD8+ T cells were examined by flow cytometry, as were the intracellular levels of cytokines in CD8+CD45RA+CD95+ and CD8+CD45RO+CD95+ T cells.
The researchers found that compared to the NTD and HC groups, the TD group had a higher percentage of CD8+CD45RO+CD95+ T cells, which correlated with the choroid plexus volume in the TD group. Associations were seen for the intracellular level of interferon-γ in CD8+CD45RO+CD95+ T cells, the fractional anisotropy (FA) of the fornix/stria terminalis, and the pallidum volume with orofacial TD, while correlations were seen for the fractional anisotropies of the inferior fronto-occipital fasciculus, cingulum, and superior longitudinal fasciculus with limb-truncal TD.
"These findings provide preliminary evidence that the association between immunosenescence-related T cell subpopulations and brain structure may underline the pathological process of TD," the authors write.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
![](/img/logo/vendor/healthday-logo.png)
© 2024 HealthDay. All rights reserved.
Posted July 2024
Read this next
SNP rs13194504 AA Genotype Linked to Severity of Tardive Dyskinesia
TUESDAY, June 25, 2024 -- For patients with schizophrenia, the single-nucleotide polymorphism (SNP) rs13194504 AA genotype is associated with reduced severity of tardive...
Electroconvulsive Therapy Safe, Effective for Range of Serious Mental Illnesses
FRIDAY, April 26, 2024 -- Electroconvulsive therapy (ECT) is a safe and effective treatment for serious mental illness, according to a study presented at the annual congress of...
Risk for Adverse Outcomes Increased With Antipsychotic Use in Dementia
FRIDAY, April 19, 2024 -- For adults with dementia, antipsychotic use is associated with increased risks for stroke, venous thromboembolism, myocardial infarction, heart failure...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.